We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Rapid7
RPD
$854M
| $664K | ﹤0.01% |
16,500
-400
| -2% | -$16.2K |
|
1177
Summit Therapeutics
SMMT
$11.8B
| $662K | ﹤0.01% |
37,100
-50,900
| -58% | -$987K |
|
|
SNRE
1178
DELISTED
Sunrise Communications AG American Depositary Shares representing Class A shares
SNRE
| $655K | ﹤0.01% |
+15,200
| New | +$695K |
|
1179
Bread Financial
BFH
$4.47B
| $653K | ﹤0.01% |
10,700
-3,300
| -24% | -$187K |
|
1180
Ziff Davis
ZD
$1.89B
| $653K | ﹤0.01% |
12,016
+2,200
| +22% | +$115K |
|
1181
IDEAYA Biosciences
IDYA
$3.56B
| $650K | ﹤0.01% |
25,300
+1,900
| +8% | +$53.8K |
|
1182
Independent Bank
INDB
$4.05B
| $650K | ﹤0.01% |
10,129
+1,300
| +15% | +$86.7K |
|
1183
Sotera Health
SHC
$5.41B
| $650K | ﹤0.01% |
47,500
+6,600
| +16% | +$95.7K |
|
1184
Associated Banc-Corp
ASB
$6.07B
| $644K | ﹤0.01% |
26,962
| – | – |
|
1185
Bank of Hawaii
BOH
$3.14B
| $644K | ﹤0.01% |
9,037
+1,500
| +20% | +$108K |
|
1186
Marriott Vacations Worldwide
VAC
$4.14B
| $644K | ﹤0.01% |
7,177
| – | – |
|
1187
Huntsman Corp
HUN
$1.82B
| $642K | ﹤0.01% |
35,613
-9,500
| -21% | -$198K |
|
1188
Janux Therapeutics
JANX
$995M
| $642K | ﹤0.01% |
+12,000
| New | +$635K |
|
1189
Newmark Group
NMRK
$2.72B
| $641K | ﹤0.01% |
50,017
+4,100
| +9% | +$60.6K |
|
1190
Agios Pharmaceuticals
AGIO
$2.01B
| $635K | ﹤0.01% |
19,323
+1,500
| +8% | +$70.5K |
|
1191
ArcBest
ARCB
$3.23B
| $635K | ﹤0.01% |
6,800
-700
| -9% | -$74K |
|
|
DVAX
1192
DELISTED
Dynavax Technologies
DVAX
| $635K | ﹤0.01% |
49,700
+4,300
| +9% | +$52K |
|
1193
Griffon
GFF
$4.79B
| $634K | ﹤0.01% |
8,900
-800
| -8% | -$58K |
|
1194
Eastern Bankshares
EBC
$5.35B
| $631K | ﹤0.01% |
36,600
+6,800
| +23% | +$119K |
|
1195
Knowles
KN
$3.31B
| $628K | ﹤0.01% |
31,490
+9,500
| +43% | +$177K |
|
1196
Ligand Pharmaceuticals
LGND
$5.73B
| $628K | ﹤0.01% |
5,858
+500
| +9% | +$56.5K |
|
1197
Wave Life Sciences
WVE
$1.06B
| $628K | ﹤0.01% |
+50,800
| New | +$678K |
|
1198
CarGurus
CARG
$3.33B
| $625K | ﹤0.01% |
17,100
+1,700
| +11% | +$58.4K |
|
1199
ICF International
ICFI
$1.56B
| $623K | ﹤0.01% |
5,222
+400
| +8% | +$59.8K |
|
1200
Goosehead Insurance
GSHD
$2.28B
| $622K | ﹤0.01% |
5,800
-1,200
| -17% | -$131K |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.